NLARx News
LEGAL CONFERENCE: Executive Director Sharon Treat Addresses National Conference on Expanding Access to Medicines More
NEW YORK HEARINGS: Policy Director Robin Lunge Testifies Before Assembly Health Committee More
|
In the States
OVERVIEW: NCSL Report on 2008 Prescription Drug Legislation Shows Strong Role for States More
STATE AGs: Attorneys General and Pharmaceuticals: Writing a New Prescription to Curtail Drug Costs More
NEW HAMPSHIRE: Hearings on Academic Detailing and Disclosure Bills MoreVERMONT: House Sticks with Data-Mining Restriction Despite Lawsuit More
DISTRICT OF COLOMBIA: New Plan Would Require D.C. Drug Detailers to Be Licensed More
WASHINGTON: Datamining Bill Strengthened in Committee MoreMINNESOTA: Universal Health Plan Unveiled MoreCALIFORNIA: Physicians Resist Providing Information that Could Lead to Policy Cancellations MoreDrug-Tracking System Faces Another Delay More
INDIANA: Higher-Than-Expected Number of People Apply to New Healthy Indiana Plan More
SOUTH CAROLINA: Collaborative Announces Plan To Cover 160,000 Uninsured Residents More |
Outrage of the Week
FRAUD: Merck to Pay Over $650 Million To Settle Pricing Suits More |
Fraud & Abuse
Durable Medical Equipment Company, Infusion Clinic Owners Sentenced for Medicare Fraud More
House Energy and Commerce Committee Subpoenas FDA Over Ketek More
Merck, Schering-Plough Accused of Fraud,
Face Multiple Zetia/Vytorin Overcharge Suits More
Jurors Urged to Award Alabama $40 Million in Case Against AstraZeneca More
|
Conflicts of Interest
Academic Medical Centers and Financial Conflicts of Interest More |
Advertising and Marketing
Drug Ads Raise Questions for Heart Pioneer More
Lilly Considers $1 Billion Fine to Settle Case More
Doctors Pitching Meds to Doctors Can Influence Prescribing Habits More
University of South Florida Doctor's Ties to Pharma: Bad Karma? More
Vanderbilt Bans Drug Rep Swag More
TV ads Oversell Drugs, Skimp on Risks More
Democratic Lawmakers To Propose Restrictions on Private Medicare Advantage Plan Sales Tactics More
Amgen & Enbrel Marketing: Crossing Another Line? More
Op Ed: Give Doctors and Patients Privacy More
|
Pharma Watch
FDA: Agency Failed to Debar Individuals, Drug Companies Convicted of Crimes, Report Finds More
FRAUD: Lilly Considers $1B Fine to Settle Case More
INVESTIGATIONS: Current events, politics fuel Big Pharma probes More
STUDY: More Using Prescription Drugs More
|
PBM Watch
CVS-Caremark Fights Off Ills More
|
Goings on in CongressFUNDING: House Lawmakers Introduce Bill To Increase Federal Medical Assistance Percentage More
FRAUD: Lawmakers To Propose Restrictions on Medicare Sales Tactics More
FDA: Congress Sends Out Many More Missives Concerning FDA More |
Medicare
Bush's Budget Proposes $560 Billion Cut More
Kaiser Issues New Medicare Part D 2008 Data More
Doctors Seek to Shift Certain Costs to Medicare Recipients More
Income Relating Part D Premiums Will Create Costly Problems for Medicare Beneficiaries More
Senate Committee May Reduce Payments, Impose Restrictions on Advantage Plans More
|
Medicaid
Congress Might Be Unable To Block New Rules That Shift Costs to States More
Maine Doctors Protest $20 Million in Medicaid Cuts More
Doctors: Higher Medicaid Fees Can't Fix Pay Gaps More
|
Safety & Clinical TrialsSenator Investigating When Company Knew of Suicide Risk for Paxil More
USA Today Investigation Examines Contributing Factors in Prescription Errors More
Waiting For ENHANCE More
Safety of Drug Imports Questioned More
FDA Amendments Act Enforcement Summary More
Bush Budget Proposes Increased Funding
For Drugs, Devices, Seeks Biotech Pathway More
Federal Grand Jury Probes Biovail Over Cardizem More
When Drug Trials Go Wrong, Patients Have Little Recourse More
|
Generics & Patent Policy
Administration Ready to Deal With Democrats On Generic Biologics Bill, Senate Panel Hears More
Short Video of "Mike," Generic Biologics Lobbyist More
Federal Trade Commission Files Amicus Brief in Ciprofloxacin "Reverse Payment" Case More
Will Big Pharma Game Systen to Avoid Shift to Generics? More
Big Pharma's Patent Headache More
FDA To Seek Authority To Approve Generic Versions of Biotechnology Drugs More
Kroger to Offer $4 Generic Prescription Drugs More
|
Editorials on FDA Weakness
Washington Post: Cholesterol Drug Study Suggests Consumers Lured Into Overspending More
NY Times: FDA Needs More Money and Talent More
|
